1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. LUPIN LTD.
2274.50 -0.40 (-0.02%)
1.3M
NSE+BSE Volume

NSE 02 Apr, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert

US FDA Approval
Lupin gets US FDA nod for ANDA for Sugammadex Injection, with an estimated market size of $8.4 bn See details

Lupin - LUPIN - stock price prediction, stock forecast, target price, analyst ratings from 37 analysts

Lupin has a share price target of Rs 2422, revenue growth forecast of 19.3%, and profit growth estimate of 49.9% for FY26, based on top 37 analyst calls.